Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Dapagliflozin
Related studies linked through entity extraction aliases.
Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor
- Status
- COMPLETED
- Phase
- PHASE4
The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.
- Status
- TERMINATED
- Phase
- PHASE4
Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension
- Status
- COMPLETED
- Phase
- PHASE4
Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
- Status
- COMPLETED
- Phase
- PHASE4
Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
- Status
- COMPLETED
- Phase
- PHASE4
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- Status
- RECRUITING
- Phase
- NA
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- NA
Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Anti-diabetic Drugs on Glycemic Variability
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
- Status
- COMPLETED
- Phase
- PHASE4
Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes.
- Status
- TERMINATED
- Phase
- PHASE4
HbA1c Variability in Type II Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA